These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35755055)

  • 41. Prognostic Factors for Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Dexamethasone Implant.
    Lee H; Kang KE; Chung H; Kim HC
    Korean J Ophthalmol; 2018 Apr; 32(2):116-125. PubMed ID: 29560616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data from a Prospective Study and Predictive Factors for Visual Outcome.
    Chatziralli I; Theodossiadis P; Parikakis E; Dimitriou E; Xirou T; Theodossiadis G; Kabanarou SΑ
    Diabetes Ther; 2017 Dec; 8(6):1393-1404. PubMed ID: 29110201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Age, Initial Central Retinal Thickness, and OCT Biomarkers Have an Influence on the Outcome of Diabetic Macular Edema Treated With Ranibizumab- Tri-center 12-Month Treat-and-Extend Study.
    Lai CT; Hsieh YT; Lin CJ; Wang JK; Lin CY; Hsia NY; Bair H; Chen HS; Chiu CY; Weng SW
    Front Med (Lausanne); 2021; 8():668107. PubMed ID: 34012972
    [No Abstract]   [Full Text] [Related]  

  • 44. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS OF RETINAL HYPERPERMEABILITY AND CHOROIDAL INFLAMMATION AS PREDICTORS OF SHORT-TERM FUNCTIONAL AND ANATOMICAL OUTCOMES IN EYES WITH DIABETIC MACULAR EDEMA TREATED WITH INTRAVITREAL BEVACIZUMAB.
    Mazloumi M; Entezari M; Samadikhadem S; Ramezani A; Nikkhah H; Arevalo JF
    Retina; 2022 Apr; 42(4):760-766. PubMed ID: 35350050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.
    Augustin AJ; Kuppermann BD; Lanzetta P; Loewenstein A; Li XY; Cui H; Hashad Y; Whitcup SM;
    BMC Ophthalmol; 2015 Oct; 15():150. PubMed ID: 26519345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
    Bonfiglio V; Reibaldi M; Pizzo A; Russo A; Macchi I; Faro G; Avitabile T; Longo A
    Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes.
    Freissinger S; Vounotrypidis E; Wolf A; Kortuem KU; Shajari M; Sakkias F; Herold T; Priglinger SG; Mayer WJ
    J Ophthalmol; 2020; 2020():3946531. PubMed ID: 32411428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
    Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
    Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
    Inan S; Polat O; Karadas M; Inan UU
    Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625
    [No Abstract]   [Full Text] [Related]  

  • 50. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and Safety of a Dexamethasone Implant in Patients with Diabetic Macular Edema at Tertiary Centers in Korea.
    Moon BG; Lee JY; Yu HG; Song JH; Park YH; Kim HW; Ji YS; Chang W; Lee JE; Oh J; Chung I
    J Ophthalmol; 2016; 2016():9810270. PubMed ID: 27293879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the Initial Optical Coherence Tomography Parameters in Anticipating the Final Visual Outcome of Central Retinal Vein Occlusion.
    Ozer MD; Batur M; Mesen S; Tekin S; Seven E
    J Curr Ophthalmol; 2020; 32(1):46-52. PubMed ID: 32510013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short-term outcomes of intravitreal dexamethasone in relation to biomarkers in diabetic macular edema.
    Narnaware SH; Bawankule PK; Raje D
    Eur J Ophthalmol; 2021 May; 31(3):1185-1191. PubMed ID: 32429696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of SDOCT Scan Types for Grading Disorganization of Retinal Inner Layers and Other Morphologic Features of Diabetic Macular Edema.
    Sampani K; Abdulaal M; Peiris T; Lin MM; Pitoc C; Ledesma M; Lammer J; Silva PS; Aiello LP; Sun JK
    Transl Vis Sci Technol; 2020 Jul; 9(8):45. PubMed ID: 32855891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of Diabetic Macular Edema with Multiple Dexamethasone Intravitreal Implants: Evidence from Real-Life Experience.
    De Geronimo D; Giorno P; Scarinci F; Boninfante A; Varano M; Parravano M
    Ophthalmologica; 2020; 243(6):413-419. PubMed ID: 31760387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome.
    Vadalà M; Sunseri Trapani V; Guarrasi G; Ventura N; Castellucci M; Cillino S
    Clin Ophthalmol; 2020; 14():2657-2665. PubMed ID: 32982158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetic macular edema with neuroretinal detachment: OCT and OCT-angiography biomarkers of treatment response to anti-VEGF and steroids.
    Vujosevic S; Toma C; Villani E; Muraca A; Torti E; Florimbi G; Leporati F; Brambilla M; Nucci P; De Cilla' S
    Acta Diabetol; 2020 Mar; 57(3):287-296. PubMed ID: 31541333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT.
    Ozsaygili C; Duru N
    Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optical Coherence Tomography Parameters Related to Vision Impairment in Patients with Diabetic Macular Edema: A Quantitative Correlation Analysis.
    Li B; Zhang B; Chen Y; Li D
    J Ophthalmol; 2020; 2020():5639284. PubMed ID: 33062313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aflibercept combined with triamcinolone acetonide in the treatment of diabetic macular edema: optical coherence tomography and optical coherence tomography angiography.
    Li DS; Liao HX; Zhang CH; Huang JG; Chen W; Zhang JL; Qin B
    Int J Ophthalmol; 2024; 17(4):670-675. PubMed ID: 38638246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.